Click on the Resource Pages Below
Physicians with expertise in aHUS diagnosis, treatment, and patient issues offer phone and/or email consultation with other medical personnel. Top aHUS clinicians and researchers from across the USA, as well as Canada and the UK, provide information and physician outreach as a volunteer service striving to improve aHUS patient outcomes.
The aHUS Clincial Channel (YouTube) offers videos packed with a wealth of solid scientific information about atypical HUS. Top researchers and clinicians in the USA and the UK present topics such as diagnosis and treatment of aHUS, genetics, the role of complement, and more.
A quick reference list for an overview of current aHUS research and journal articles. Additional material is available in the family Research Forum.
"Within the last two decades, major advances in our understanding of the thrombotic microangiopathies has greatly expanded the boundaries of our knowledge base and enabled us to view these disorders in a fresh perspective. Misconceptions existed concerning aspects of the disease relevant to securing the correct diagnosis and selecting the optimal treatment approach." Read more....
Dispelling Common Misperceptions in aHUS
Presented to The Western Pennsylvania-Allegheny Health System (WPAHS)
at Pittsburgh, PA on February 20,2013 (Revised Aug. 2013)
by Robert B. Kaplan, MD
The aHUS Center of Excellence is a component of the Carver College of Medicine at the University of Iowa. The overarching objective of the University of Iowa Pediatric Nephrology Center of Excellence is to improve the healthcare of patients with atypical Hemolytic Uremic Syndrome (aHUS) and other aHUS-like diseases through a collaborative effort focused on the presentation, rapid diagnosis, underlying genetics and pathophysiology of aHUS.
Cincinnati Children’s Hospital Medical Center offers a broad platform of molecular and cellular diagnostic testing for thrombotic microangiopathies (TMA), including atypical hemolytic uremic syndrome (aHUS) and thrombotic thrombocytopenia purpura (TTP). Test results are incorporated in a customized summary, where clinical information is incorporated with the genetic, biochemical and functional test results.
Cincinnati Children’s has board-certified pediatric nephrologists, hematologists, molecular geneticists and genetic counselors to provide telephone or email consultations to referring physicians regarding test selection, clinical interpretation, medical management and follow-up testing, genetic counseling, and additional studies of at-risk family members
General Contact Information for Cincinnati Children’s:
Phone: 513-636-4530 Fax: 513-636-8924 Email: firstname.lastname@example.org
Contact the thrombotic microangiopathy team:
Dr. Ralph A. Gruppo Director, Comprehensive Hemophilia and Thrombosis Center
Phone: 513-636-4269 Email: email@example.com
Dr. Bradley P. Dixon
Phone: 513-636-4531 Email: firstname.lastname@example.org
Molecular Otolaryngology and Renal Research Laboratories (MORL) are recognized nationally and internationally for their expertise in the area of complement-mediated renal diseases and as leaders in genetic testing for deaf and hard-of-hearing persons.
MORL is associated with the Rare Renal Disease and Renal Genetics Clinic at the University of Iowa serves as a national referral center by providing evaluation and management services for children and adults with membranoproliferative glomerulonephritis type I, atypical hemolytic uremic syndrome, dense deposit disease and C3 glomerulonephritis, in addition to inherited renal diseases such as Fabry’s disease, nephronophthisis, polycystic kidney disease and congenital diseases of the kidney.
General Contact Information for MORL:
Phone: 319-335-6623 Fax: 319-353-5869 Email: email@example.com
For More Information Contact:
Dr. Richard JH Smith Director, MORL
Phone: 319- 356-3612 Email: firstname.lastname@example.org
BloodCenter of Wisconsin, a pioneer in diagnostics, offers a comprehensive laboratory panel for evaluation of patients with thrombotic microangiopathy (TMA) in 28 days, including a rapid genetic evaluation to support diagnosis of Atypical Hemolytic Uremic Syndrome (aHUS).
For questions please contact:
Phone: 800-245-3117, ext. 6250
Machaon Diagnostics is a specialty bleeding and clotting clinical reference laboratory running the fastest testing in the country for thrombotic microangiopathies (TMA).
We offer a 24-hour turnaround time for ADAMTS-13 testing used to diagnose thrombotic thrombocytopenia purpura (TTP) and our aHUS Genetic Panel™ has a 48 hour turnaround time. This test is sometimes used by clinicians to confirm their clinical diagnosis of atypical hemolytic uremic syndrome (aHUS).
Machaon Diagnostics provides this aHUS testing to doctors and hospitals all over the country and can provide draw kits with pre-paid shipping upon request. Each report from Machaon Diagnostics comes with the direct phone number of our medical director who has significant experience with TMAs.
General Contact Information for Machaon Diagnostics:
3023 Summit Street
Oakland, CA 94609
Phone: 510-839-5600 Fax: 510-839-6153
An overview of outreach and education materials are listed (brochures, aHUS Bootcamp, Rare Disease Resource List, and MORE!) that offer information and insight into atypical hemolytic uremic syndrome, a complex and ultra-rare disease.
Physicians wishing to explore the use of eculizumab (Soliris®) therapy for patients with atypical HUS are advised to directly contact Alexion Pharmaceuticals, makers of Soliris ® for information related to the only drug approved by the FDA for treatment of atypical hemolytic uremic syndrome.
FMI, call 1-888-SOLIRIS.
Alexion offers OneSource™, a program that provides education, assistance with access to Soliris, and treatment support for patients and their caregivers. Each patient who enrolls in OneSource will receive one-to-one support from an Alexion Nurse Case Manager who helps coordinate care and assist with obtaining reimbursement. All Nurse Case Managers are registered nurses who have extensive experience caring for patients and working in the health insurance industry.
To learn more, call 1-888-SOLIRIS or visit www.Soliris.net/patients/one-source.
Rare Disease Challenges: Support for Patients & Families VIDEO: Featuring Jody L. Jones, Ph.D., Clinical Psychologist (University of Iowa, Transplant Program)
A chronic illness or rare disease diagnosis affects all individuals and groups associated with the patient. Managing medical aspects may impact family dynamics, personal relationships, professional or work areas, and other interactions across all facets of everyday life.
The video’s Resource List provides links to organizations and resources that offer assistance to those challenged with rare disease issues and concerns. Our Patient & Family Assistance Tips suggest ideas for friends, relatives, coworkers, or community members to offer support.
Printable Page –Video QR code with Resource List Link. Distribute to patients/families/caregivers.
Hundreds of resource links to inform and support patients, families, and professions.
Questions? Please contact Linda@atypicalhus.org